Skip Nav Destination
Issues
1 February 2016
-
Cover Image
Cover Image
About the Cover
Tumors create havoc by making their own rules. How cancer cells may travel and seed a new site, such as the immune-privileged eye, is not always clear. A case of “Trojan horse” travel is described by Grajewski and colleagues starting on p. 92 in this issue of Cancer Immunology Research. A covert parotid carcinoma may have traveled to the aqueous humor of the eye by fusing with migratory phagocytic cells to create monocyte–macrophage Trojan horses. The eye's trabecular network trapped these cells (the yellow section, lower left, of the iris), and they proliferated, causing a rare type of carcinoma in the aqueous humor. Artwork is by Lewis Long. - PDF Icon PDF LinkTable of Contents
ISSN 2326-6066
EISSN 2326-6074
Journal Archive
Cancer Immunology Research (2013-Present)
(ISSN 2326-6066) Published monthly since 2013.Cancer Immunity (2001-2013; volumes 1-13)
(EISSN 1424-9634) Published periodically from 2001-2013.Table of Contents
Cancer Immunology at the Crossroads: Tumor Microenvironment
Cancer Immunology Miniatures
Priority Brief
Research Articles
Retuning of Mouse NK Cells after Interference with MHC Class I Sensing Adjusts Self-Tolerance but Preserves Anticancer Response
Arnika Kathleen Wagner; Stina Linnea Wickström; Rossana Tallerico; Sadia Salam; Tadepally Lakshmikanth; Hanna Brauner; Petter Höglund; Ennio Carbone; Maria Helena Johansson; Klas Kärre
Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model
David A. Reardon; Prafulla C. Gokhale; Sarah R. Klein; Keith L. Ligon; Scott J. Rodig; Shakti H. Ramkissoon; Kristen L. Jones; Amy Saur Conway; Xiaoyun Liao; Jun Zhou; Patrick Y. Wen; Annick D. Van Den Abbeele; F. Stephen Hodi; Lei Qin; Nancy E. Kohl; Arlene H. Sharpe; Glenn Dranoff; Gordon J. Freeman
Hypomethylation of the Treg-Specific Demethylated Region in FOXP3 Is a Hallmark of the Regulatory T-cell Subtype in Adult T-cell Leukemia
Yayoi Shimazu; Yutaka Shimazu; Masakatsu Hishizawa; Masahide Hamaguchi; Yuya Nagai; Noriko Sugino; Sumie Fujii; Masahiro Kawahara; Norimitsu Kadowaki; Hiroyoshi Nishikawa; Shimon Sakaguchi; Akifumi Takaori-Kondo
Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic Cells
Sandra Van Lint; Dries Renmans; Katrijn Broos; Lode Goethals; Sarah Maenhout; Daphné Benteyn; Cleo Goyvaerts; Stephanie Du Four; Kevin Van der Jeught; Lukasz Bialkowski; Véronique Flamand; Carlo Heirman; Kris Thielemans; Karine Breckpot
Survivin Autoantibodies Are Not Elevated in Lung Cancer When Assayed Controlling for Specificity and Smoking Status
Ingrid Broodman; Martijn M. VanDuijn; Christoph Stingl; Lennard J.M. Dekker; Anastasios E. Germenis; Harry J. de Koning; Rob J. van Klaveren; Joachim G. Aerts; Jan Lindemans; Theo M. Luider
Correction
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.